Form 4: ANI Pharmaceuticals Executive Chad Gassert Reports Acquisition of Shares Through Stock Awards

Chad Gassert, SVP of Corporate Development & Strategy at ANI Pharmaceuticals, reports acquiring shares through restricted stock awards and performance stock units.

Summary

• Chad Gassert, a Senior Vice President at ANI Pharmaceuticals, filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
• On February 12, 2025, Gassert acquired 14,362 shares of common stock through a restricted stock award that vests in equal annual installments over four years.
• He also acquired 9,574 shares through performance stock units, which vest based on the achievement of performance targets.
• Following these transactions, Gassert directly owns 73,615 shares of ANI Pharmaceuticals common stock.
• Additionally, he indirectly owns 193,226 shares held by Chali Properties LLC, over which he has voting and dispositive power.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock ownership changes, indicating a neutral sentiment.

Future Outlook

The restricted stock award will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025. The performance stock units will vest over the applicable performance period based on the achievement of the provided performance targets.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in the pharmaceutical industry.

Stakeholder Impact

• The vesting of stock awards and performance stock units aligns executive interests with shareholder value.

Key Dates

Keywords

Form 4, Beneficial Ownership, ANI Pharmaceuticals, ANIP, Chad Gassert, Stock Awards, Restricted Stock, Performance Stock Units